Digital Health Roundtable Series

In March of 2022, UCB commenced their quarterly Digital Health Roundtable Series. These Roundtables bring together experts inside and outside of Stanford and UCB to explore key topics in the digital health field. 

March 8, 2022: Digital Biomarkers and Phenotyping

The first Digital Health Roundtable was centered around leveraging patient-generated heatlh data for digital phenotyping and biomarker development in research and development. 

  • Erin Rainaldi, MS 
    • Head of Sensors Data Science, Verily
  • Jen Goldsack, MChem, MA, MBA, OLY
    • Chief Executive Officer, Digital Medicine Society (DIME)
  • Loren Nelson, PhD, MS
    • Associate Professor, Stanford University
    • Department of Epidemiology and Population Health
  • Francesca Rinaldo, MD, PhD
    • SVP, Clinical Product and Innovation, Sharecare

June 3, 2022: Creative Evidence Generation Strategies implementing RWD/RWE

The June 2022 Roundtable focused on using Real World Data and Real World Evidence in clinical study design and decision making. 

  • Dorothee Bartels, PhD
    • Former Global Head of Real World Evidence and Digital Sciences, UCB Biopharma
  • Ying Lu, PhD
    • Professor of Biomedical Data Science, Stanford University
  • Jeremy Rassen, Sc.D
    • Co-Founder and President, Aetion, Inc. 
  • Devin Gilliam
    • Head of Clinical Trials, Datavant